HEMP LEGAL MAP
Sign in

State

Listings in New Mexico

0 listings serving New Mexico. Compare fees, capabilities and credentials.

Status by product class in New Mexico

Product classStatusChannelCapsMin ageEffectiveNext changeStatuteChecked
Hemp delta-9 ediblesLegal at general retailAny store2 mg per serving; 20 mg per package—Mar 29, 2026—20.10.2.12 NMAC (Hemp Manufacturing Act, NMSA 1978 §76-24-1 et seq.)Oct 8, 2026
THC drinksLegal at general retailAny store2 mg per serving; 20 mg per package—Mar 29, 2026—20.10.2.12 NMACOct 8, 2026
THCA flower & pre-rollsNot yet confirmedUnclear——Jan 28, 2026—20.10.2.7 NMAC (definition of total THC)Oct 8, 2026
Delta-8 & converted cannabinoidsNot yet confirmedUnclear——Jan 28, 2026—20.10.2.11(K)-(L) NMACOct 8, 2026
Lab-made cannabinoidsNot yet confirmedUnclear——Jan 28, 2026—20.10.2.11(K)-(L) NMACOct 8, 2026
Vapes & cartridgesNot yet confirmedUnclear——Mar 29, 2026—20.10.2.12 NMACOct 8, 2026
CBD (≤0.4 mg THC per container)Legal at general retailAny storeBroad spectrum 6 mg per package—Mar 29, 2026—20.10.2.12 NMACOct 8, 2026

As of Oct 10, 2026. Every row names its statute and the day we checked it. Grey rows are on the verification queue. Not legal advice.

Dates and deadlines that apply

Full timeline →

  1. Dec 11, 2026 · Effective · US

    Federal: total THC incl. THCA, 0.4 mg per container, converted delta-8

    H.R. 6500 (signed Sep 2, 2026) provides that until Dec 11, 2026 the §781 amendments apply only to non-natural-cannabinoid products. So from Dec 11, 2026 the rest applies: hemp means total THC including THCA at 0.3% or less by dry weight; final products above 0.4 mg combined total THC per container are excluded; cannabinoids the plant can make but that were synthesized or manufactured outside it (commercial delta-8 converted from CBD) are excluded. DEA separately holds that chemically converted THCs are already Schedule I (91 FR 23913).

    P.L. 119-103 (H.R. 6500), Div. B §2019 'Section 781 Extension'; P.L. 119-37 §781 · H.R. 6500 enrolled text = P.L. 119-103, approved Sep 2, 2026 (govinfo) · verified Oct 8, 2026

  2. Dec 11, 2026 · Deadline · US

    Federal funding bill expires

    The Continuing Appropriations and Extensions Act, 2027 funds the government through Dec 11, 2026, the same day the rest of the hemp redefinition takes effect. The next spending bill is the most likely vehicle for any further change to the hemp dates; the OMB letter of Jun 24, 2026 asked Congress for 'at minimum, an extension' of §781's implementation.

    Scheduled; may move — Dec 11 is also the continuing-resolution expiry and the OMB letter of Jun 24, 2026 asked Congress for 'at minimum, an extension'

    P.L. 119-103 (H.R. 6500), Div. A §106(3) · H.R. 6500 enrolled text, Div. A §106 (govinfo); OMB letter Jun 24, 2026 · verified Oct 8, 2026

  3. Nov 12, 2026 · Effective · US

    Federal: cannabinoids the plant cannot make leave the hemp definition

    From Nov 12, 2026 (365 days after enactment) intermediate and final hemp-derived cannabinoid products containing cannabinoids 'not capable of being naturally produced by a Cannabis sativa L. plant' (subclauses (1)(C)(ii)(I) and (iv)(I)) are no longer hemp and fall under the Controlled Substances Act. Until Dec 11, 2026 this is the only part of §781 that applies. On Oct 8, 2026 we found no FDA list that names which cannabinoids qualify (a dated search; see the row on FDA's lists).

    P.L. 119-37, Div. B §781 (7 U.S.C. 1639o note), as limited by P.L. 119-103, Div. B §2019 · P.L. 119-37 (govinfo); P.L. 119-103, Div. B §2019 (govinfo) · verified Oct 8, 2026

No listings listed here yet.

Know one? Add or claim a listing — it is free.